)
)
Emily Pegg
Associate Vice President, Medical Northern European Hub,
Lilly
Dr Emily Pegg has over a decade of experience in the pharmaceutical industry, starting at Novartis, where for 5 years she worked in both UK and regional roles in its Neuroscience franchise. In late 2018, Emily moved to Shire shortly before its acquisition by Takeda, where she was the Country Medical Lead for Genetic Diseases and later Head of Medical Affairs for Oncology.
Most recently, Emily held the role of Associate Medical Director for Takeda UK and Ireland before moving to Lilly in 2023 to take up the role of Associate Vice President – Medical, Northern European Hub. Prior to her career in the pharmaceutical industry Emily trained as a clinical doctor in the NHS and is a Member of the Faculty of Pharmaceutical Medicine.
Sessions
-
The evolving diagnostic landscape: are you ready?12-Jun-2025Exchange 8-10